Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07136844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Study acronym: Acti-Adult
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Centre Hospitalier Universitaire de Liege
26 trials monitored
See all monitored trials
Obesity
3,874 trials monitored
See 152 trials at risk
Dementia
1,978 trials monitored
See 106 trials at risk
Myasthenia Gravis
193 trials monitored
See 7 trials at risk
and 1 more disease
The ActiLiège-Adult study is a prospective, longitudinal, observational study designed to collect natural history data on adult patients with neurological or metabolic diseases affecting movement. Conducted at the Centre de Référence Liégeois des Maladies Neuromusculaires in Liège, Belgium, the study will enroll 300 ambulant patients, including individuals with neuromuscular disorders and obesity. Using the Syde® wearable device, the study aims to continuously monitor motor function in real-life settings over a period of up to two years. The primary objective is to evaluate the utility of digital mobility outcomes, such as the 95th centile of stride velocity (SV95C), as reliable and objective endpoints for future clinical trials.
Trial Details
NCT Number NCT07136844
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: Centre Hospitalier Régional de la Citadelle, SYSNAV
Conditions
(from sponsor)		 Neuromuscular Diseases, Obesity (Disorder), Myotonic Dystrophy 1, Myasthenic Syndrome, Charcot Marie Tooth Disease (CMT), Glycogen Storage Disease Type II Pompe Disease, Facio-Scapulo-Humeral Dystrophy, Myasthenia Gravis +4 more
Related terms Charcot-Marie-Tooth Disease, Huntington Disease, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Spastic Paraplegia, Hereditary, Spinocerebellar Ataxias, Supranuclear Palsy, Progressive
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov